Literature DB >> 2810399

Vitamin K-reversible hypoprothrombinemia in rats: comparison of hypoprothrombinemic changes in various strains of rats caused by vitamin K deficiency and antibiotic treatment.

M Matsuura1, S Satoh, F Kobayashi, K Uchida, T Matsubara.   

Abstract

Hypoprothrombinemic changes were compared in rats fed various vitamin K-deficient diets. Changes such as prolongation of prothrombin time and activated partial thromboplastin time, decrease in plasma levels of prothrombin and clotting factor VII, and increase in plasma descarboxyprothrombin, appeared in rats maintained on vitamin K-deficient diet, but in rats on ordinary diet (vitamin K-sufficient diet). As the development of hypoprothrombinemia was not significantly different among animals fed various vitamin K-deficient diets, the blood coagulation parameters were concluded to be regulated only by the vitamin K level. Following the development of hypoprothrombinemia, hemorrhaging in various organs was detected in vitamin K-deficient rats, with strain differences in the severity of hemorrhage; Fischer and Wistar strains were more sensitive than the Sprague Dawley strain. Administration of a beta-lactam antibiotic, latamoxef (LMOX), to vitamin K-deficient rats led to enhancement of the hypoprothrombinemic conditions, but LMOX-associated changes in plasma enzyme levels were not detected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810399     DOI: 10.2131/jts.14.165

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  2 in total

1.  Vitamin K supplementation during prophylactic use of cefoperazone in urologic surgery.

Authors:  S D Rockoff; M J Blumenfrucht; R J Irwin; R H Eng
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 2.  Modeling trauma in rats: similarities to humans and potential pitfalls to consider.

Authors:  Birte Weber; Ina Lackner; Melanie Haffner-Luntzer; Annette Palmer; Jochen Pressmar; Karin Scharffetter-Kochanek; Bernd Knöll; Hubert Schrezenemeier; Borna Relja; Miriam Kalbitz
Journal:  J Transl Med       Date:  2019-09-05       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.